Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus F Templin

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Nature Methods|November 27, 2008
On display on a bug: a systematic approach to characterize antibodiesThomas Knorpp, Markus F Templin
Current Protocols in Protein Science|April 23, 2008
Protein microarraysStefan Kramer, Thomas O Joos, Markus F Templin
Current Opinion in Chemical Biology|February 6, 2002
Miniaturised multiplexed immunoassaysThomas O Joos, Dieter Stoll, Markus F Templin
Current Opinion in Drug Discovery & Development|March 24, 2005
Protein microarrays: applications and future challengesDieter Stoll, Markus F Templin, Jutta Bachmann, et al.
Combinatorial Chemistry & High Throughput Screening|May 12, 2004
Protein microarrays and multiplexed sandwich immunoassays: what beats the beads?Markus F Templin, Dieter Stoll, Jutta Bachmann, et al.
Drug Discovery Today|April 12, 2013
Microarray technology: an increasing variety of screening tools for proteomic researchDieter Stoll, Jutta Bachmann, Markus F Templin, et al.
Biotechniques|January 8, 2003
Cell microarrays: an emerging technology for the characterization of antibodiesJochen M Schwenk, Dieter Stoll, Markus F Templin, et al.
Analytical and Bioanalytical Chemistry|September 23, 2008
Protein microarrays for diagnostic assaysMichael Hartmann, Johan Roeraade, Dieter Stoll, et al.
Proteomics|March 19, 2009
Proteome wide screening using peptide affinity captureOliver Poetz, Sibylle Hoeppe, Markus F Templin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 18, 2018
Mouse Hepatomas with <i>Ha-ras</i> and <i>B-raf</i> Mutations Differ in Mitogen-Activated Protein Kinase Signaling and Response to Constitutive Androstane Receptor ActivationAlbert Braeuning, Ferdinand Kollotzek, Eva Zeller, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Nature Methods|November 27, 2008
On display on a bug: a systematic approach to characterize antibodiesThomas Knorpp, Markus F Templin
Current Protocols in Protein Science|April 23, 2008
Protein microarraysStefan Kramer, Thomas O Joos, Markus F Templin
Current Opinion in Chemical Biology|February 6, 2002
Miniaturised multiplexed immunoassaysThomas O Joos, Dieter Stoll, Markus F Templin
Current Opinion in Drug Discovery & Development|March 24, 2005
Protein microarrays: applications and future challengesDieter Stoll, Markus F Templin, Jutta Bachmann, et al.
Combinatorial Chemistry & High Throughput Screening|May 12, 2004
Protein microarrays and multiplexed sandwich immunoassays: what beats the beads?Markus F Templin, Dieter Stoll, Jutta Bachmann, et al.
Drug Discovery Today|April 12, 2013
Microarray technology: an increasing variety of screening tools for proteomic researchDieter Stoll, Jutta Bachmann, Markus F Templin, et al.
Biotechniques|January 8, 2003
Cell microarrays: an emerging technology for the characterization of antibodiesJochen M Schwenk, Dieter Stoll, Markus F Templin, et al.
Analytical and Bioanalytical Chemistry|September 23, 2008
Protein microarrays for diagnostic assaysMichael Hartmann, Johan Roeraade, Dieter Stoll, et al.
Proteomics|March 19, 2009
Proteome wide screening using peptide affinity captureOliver Poetz, Sibylle Hoeppe, Markus F Templin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 18, 2018
Mouse Hepatomas with <i>Ha-ras</i> and <i>B-raf</i> Mutations Differ in Mitogen-Activated Protein Kinase Signaling and Response to Constitutive Androstane Receptor ActivationAlbert Braeuning, Ferdinand Kollotzek, Eva Zeller, et al.
Pageof 6